A bill to amend the Public Health Service Act with respect to the drug discount program, and for other purposes.

S. 5244 would amend the Public Health Service Act's provisions governing the 340B drug discount program, though the specific changes it would make are not yet available in the published bill text. Since the bill was introduced on 2026-08-05 without accompanying legislative text, only its title, sponsor, and status are currently known.

The 340B program allows certain hospitals and other healthcare providers serving low-income or vulnerable populations to purchase outpatient drugs from manufacturers at reduced prices. Because the bill's specific provisions are not yet public, it is not possible to say which participants — providers, drug manufacturers, or patients — would be affected or how, until the full text is released.

The bill was introduced in the Senate on 2026-08-05 by Sen. Jerry Moran (R-KS) and referred to committee, which is the standard next step for a newly introduced bill. Its current status is "Introduced," meaning it has not yet been scheduled for a committee vote, floor vote, or further action. Further progress — including release of the full bill text, committee consideration, and possible amendments — would need to occur before its effects can be assessed in detail.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.